UBX Domain Protein 6 Positively Regulates JAK-STAT1/2 Signaling

J Immunol. 2021 Jun 1;206(11):2682-2691. doi: 10.4049/jimmunol.1901337. Epub 2021 May 21.

Abstract

Type I/III IFNs induce expression of hundreds of IFN-stimulated genes through the JAK/STAT pathway to combat viral infections. Although JAK/STAT signaling is seemingly straightforward, it is nevertheless subjected to complex cellular regulation. In this study, we show that an ubiquitination regulatory X (UBX) domain-containing protein, UBXN6, positively regulates JAK-STAT1/2 signaling. Overexpression of UBXN6 enhanced type I/III IFNs-induced expression of IFN-stimulated genes, whereas deletion of UBXN6 inhibited their expression. RNA viral replication was increased in human UBXN6-deficient cells, accompanied by a reduction in both type I/III IFN expression, when compared with UBXN6-sufficient cells. Mechanistically, UBXN6 interacted with tyrosine kinase 2 (TYK2) and inhibited IFN-β-induced degradation of both TYK2 and type I IFNR. These results suggest that UBXN6 maintains normal JAK-STAT1/2 signaling by stabilizing key signaling components during viral infection.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adaptor Proteins, Vesicular Transport / immunology*
  • Animals
  • Autophagy-Related Proteins / immunology*
  • Cells, Cultured
  • Chlorocebus aethiops
  • Humans
  • Janus Kinases / immunology*
  • STAT1 Transcription Factor / immunology*
  • STAT2 Transcription Factor / immunology*
  • Signal Transduction / immunology

Substances

  • Adaptor Proteins, Vesicular Transport
  • Autophagy-Related Proteins
  • STAT1 Transcription Factor
  • STAT1 protein, human
  • STAT2 Transcription Factor
  • STAT2 protein, human
  • UBXN6 protein, human
  • Janus Kinases